Blossom Pulse Archive
What happened in psychedelic research in 1966
4 events from 1966, dated by when they happened rather than when we logged them. Papers as they published, trials starting and finishing, programme milestones, and the news coverage around them, grouped by week.
Browse by year
Week of 1 August 1966
This pilot study of 27 professionally employed men found that a single, carefully structured psychedelic session with LSD-25 or mescaline appeared to facilitate creative problem‑solving, especially during the “illumination” phase. Subjective reports, creativity tests and assessments of solution utility suggested that enhanced creative ability persisted for some participants for several weeks afterwards.
LSDMescalineCreativitySet & Setting
Week of 27 December 1965
This unregistered trial (n=75) was a partially randomised, placebo-controlled evaluation of a single 500 µg oral dose of LSD for alcohol use disorder in an inpatient rehabilitation setting, which found higher abstinence rates in non-schizophrenic participants at one year.
LSDThis unregistered trial (n=128) was an open-label clinical series of single-dose LSD for anticipatory anxiety and pain in pre-terminal cancer patients, which demonstrated a reduction in psychological distress and improved sleep patterns.
LSDRandomized controlled three-year investigation comparing three LSD treatment conditions (hypnodelic, psychedelic, and drug-alone) against a milieu therapy control in 176 male alcoholic inpatients at Mendota State Hospital, Wisconsin. All groups improved significantly across all follow-up periods; no LSD condition outperformed the control.
LSD
Showing 4 of 4 in 1966